Last 48.10
Change Today 0.00 / 0.00%
Volume 0.0
KTOV On Other Exchanges
Symbol
Exchange
Tel Aviv
As of 10:24 AM 08/28/14 All times are local (Market data is delayed by at least 15 minutes).

kitov pharmaceuticals holdin (KTOV) Snapshot

Open
$48.80
Previous Close
$48.80
Day High
$49.90
Day Low
$47.10
52 Week High
10/8/13 - $288.00
52 Week Low
07/27/14 - $43.00
Market Cap
27.7M
Average Volume 10 Days
625.0K
EPS TTM
$-0.19
Shares Outstanding
57.5M
EX-Date
10/30/12
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for KITOV PHARMACEUTICALS HOLDIN (KTOV)

Related News

No related news articles were found.

kitov pharmaceuticals holdin (KTOV) Related Businessweek News

No Related Businessweek News Found

kitov pharmaceuticals holdin (KTOV) Details

Kitov Pharmaceuticals Holdings Ltd. is engaged in developing drugs. The company’s products include KIT-301 and KIT-302 for the treatment of osteoarthritis. It has an agreement with Sterling Pharmaceutical Services to manufacture and test the KIT-302 Phase 3 clinical trial supplies. The company was formerly known as Mainrom Line Logistics Ltd. and changed its name to Kitov Pharmaceuticals Holdings Ltd. in August 2013. Kitov Pharmaceuticals Holdings Ltd. is based in Jerusalem, Israel.

kitov pharmaceuticals holdin (KTOV) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kitov pharmaceuticals holdin (KTOV) Key Developments

Kitov Pharmaceutical Holdings Ltd. Signs Strategic Cooperation Agreement with Dexcel Pharma Ltd

Kitov Pharmaceutical Holdings Ltd. has signed a strategic cooperation agreement with Dexcel Pharma Ltd. to develop and produce its treatment for hypertension, KIT-302. Kitov is preparing a Phase III clinical trial of the drug. Dexcel will develop drug's final formulation for the filing of a New Drug Application with the US Food and Drug Administration. Kitov will pay Dexcel $2 million in cash and $1.5 million in shares to use the company's facilities. Dexcel will pay Kitov $500,000 in two equal installments, and will have the first right in global marketing negotiations and commercial production of KIT-302.

Kitov Pharmaceuticals Holdings LTD Auditor Raises 'Going Concern' Doubt

Kitov Pharmaceuticals Holdings LTD filed its Annual on Mar 27, 2014 for the period ending Dec 31, 2013. In this report its auditor, Somekh Chaikin, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Kitov Pharmaceuticals Holdings LTD, Special/Extraordinary Shareholders Meeting, Jan 12, 2014

Kitov Pharmaceuticals Holdings LTD, Special/Extraordinary Shareholders Meeting, Jan 12, 2014., at 14:00 E. Europe Standard Time.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KTOV:IT 48.10 0.00

KTOV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KTOV.
View Industry Companies
 

Industry Analysis

KTOV

Industry Average

Valuation KTOV Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KITOV PHARMACEUTICALS HOLDIN, please visit www.kitovpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.